SBC Medical Group Holdings Incorporated financials
$4.84−3.78%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49.2M | $43.1M | $39.6M | $43.4M | $43.4M | $47.3M | $44.4M | $53.1M | $29.80B | $30.03B | $32.02B | $30.35B |
| Gross profit | $36.0M | $30.3M | $28.9M | $30.6M | $30.0M | $37.7M | $33.9M | $43.2M | $18.36B | $18.07B | $18.11B | $18.30B |
| Gross margin | 73.1% | 70.5% | 73.1% | 70.6% | 69.2% | 79.7% | 76.3% | 81.5% | 61.6% | 60.2% | 56.6% | 60.3% |
| Operating income | $19.0M | $17.7M | $12.8M | $15.9M | $14.6M | $24.2M | $4.7M | $13.8M | $5.76B | $5.85B | $5.27B | $5.78B |
| Net income | $10.7M | $11.3M | $14.2M | $12.8M | $2.5M | $21.5M | $6.5M | $2.8M | $3.55B | $3.40B | $2.13B | $3.44B |
| Net margin | 21.7% | 26.3% | 35.9% | 29.6% | 5.7% | 45.4% | 14.7% | 5.3% | 11.9% | 11.3% | 6.7% | 11.3% |
| Diluted EPS | $0.10 | $0.11 | $0.14 | $0.12 | $0.02 | $0.21 | $0.06 | $0.03 | $0.49 | $0.47 | $0.30 | $0.48 |
| EBITDA | $20.1M | $18.4M | $13.5M | $16.6M | $15.2M | $24.8M | $20.7M | $14.9M | $11.31B | $11.05B | $5.86B | $11.09B |
| Operating cash flow | $22.5M | $9.2M | $52.0M | -$20.9M | -$8.3M | $1.9M | -$7.3M | $5.0M | $9.09B | $7.55B | $11.38B | $10.34B |
| Free cash flow | $22.0M | $8.7M | $51.0M | -$21.1M | -$8.9M | $1.2M | -$7.9M | $3.8M | $4.73B | $3.79B | $6.78B | $5.69B |
| Diluted shares | 102.6M | 102.6M | 102.6M | 102.6M | 103.5M | 103.3M | 102.8M | 95.1M | 7,198.0M | 7,193.0M | 7,193.0M | 7,185.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $184.3M | $167.3M | $163.8M | $127.4M | $152.7M | $132.1M |
| Short-term investments | $14.0M | $13.6M | $13.2M | $9.8M | $9.1M | $7.3M |
| Total debt | $37.9M | $40.6M | $43.1M | $21.4M | $10.7M | $7.2M |
| Total assets | $406.7M | $388.0M | $380.4M | $321.4M | $315.3M | $284.6M |
| Total liabilities | $126.7M | $117.6M | $117.1M | $73.3M | $70.6M | $58.3M |
| Shareholders' equity | $279.9M | $270.4M | $263.3M | $248.1M | $244.7M | $226.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology